Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/165/)
Great East Energy, Inc. (GASE) announced that it has raised $1,490,000 in a Common Stock transaction. The common stock was sold at $1.00 per share, an approximate 50% premium to the market price ($0.67) of GASE at deal announcement. via PlacementTracker.
Cytokinetics, Inc. (CYTK) announced that it has raised $35,000,000 in a CMPO/Overnight transaction. The common stock was sold at $8.00 per share, an approximate 19% discount to the market price ($9.85) of CYTK at deal announcement. Cowen and Company acted as Sole Bookrunner, with JMP Securities acting acting as Lead Manager, and Canaccord Genuity acting as Co-Manager on the transaction. Underwriter counsel was Goodwin Procter and issuer counsel was Cooley. The transaction is expected to close by 02/25/2014.
Cardiome Pharma Corporation (CRME) announced that it has secured up to $30,000,000 in an ATM (At the Market) transaction with MLV & Co. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was LeClairRyan, PC and issuer counsels were Blake, Cassels & Graydon and Skadden, Arps, Slate, Meagher & Flom. via PlacementTracker.
dELiA*s, Inc. (DLIA) announced that it has raised $44,100,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.80 per share, an approximate 6.67% premium to the market price ($0.75) of DLIA at deal announcement. Janney Montgomery Scott, Inc. acted as the exclusive agent on the transaction. The investors include Cooper Creek Partners and Valinor Capital Partners. Issuer counsel was Troutman Sanders, LLP.
